Literature DB >> 26178421

Challenging the understanding of significant improvement and outcome in schizophrenia - the concept of reliable and clinically significant change methods.

Rebecca Schennach1,2, Hans-Jürgen Möller1, Michael Obermeier1, Florian Seemüller1, Markus Jäger1, Max Schmauss3, Gerd Laux4, Herbert Pfeiffer5, Dieter Naber6, Lutz G Schmidt7, Wolfgang Gaebel8, Joachim Klosterkötter9, Isabella Heuser10, Wolfgang Maier11, Matthias R Lemke12, Eckart Rüther13, Stefan Klingberg14, Markus Gastpar15, Richard Musil1, Ilja Spellmann1, Michael Riedel1,16.   

Abstract

Significant changes of schizophrenia patients during inpatient treatment were evalutaed and compared to established outcome criteria. The concept of reliable and clinically significant change methods was applied to three hundred and ninety-six patients suffering from a schizophrenia spectrum disorder. First, information on whether or not the change of the patient's condition is sufficient in order to declare that it is beyond a measurement error or random effect (= reliable change) was evaluated and in a second step it was observed if the reliable change was clinically meaningful (= clinically significant change). Different Positive and Negative Syndrome Scale for Schizophrenia (PANSS) thresholds were applied to define the clinically significant change (40, 45 and 50 points). These changes were then compared to established outcome criteria such as response and remission. Seventy-nine of the 396 patients (20%) showed a reliable improvement of symptoms, whereas 70% improved without achieving a reliable change of their condition. Of the 79 patients achieving a reliable change during treatment 8-15% concurrently showed a clinically significant change depending on the respective PANSS threshold. In contrast, 56% of the patients achieved response and 60% were in remission at discharge when applying established outcome criteria. Our results showed that a rather small number of schizophrenia patients were found to reliably change during inpatient treatment, with even less patients achieving a clinically significant change. The concept of reliable and clinically significant changes revealed to be a lot more stringent than today's established outcome criteria and should be critically evaluated regarding its use in schizophrenia patients.
Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  clinically significant change; outcome; reliable change; schizophrenia

Mesh:

Year:  2015        PMID: 26178421      PMCID: PMC6877263          DOI: 10.1002/mpr.1476

Source DB:  PubMed          Journal:  Int J Methods Psychiatr Res        ISSN: 1049-8931            Impact factor:   4.035


  33 in total

1.  Defining clinically meaningful change in health-related quality of life.

Authors:  Ross D Crosby; Ronette L Kolotkin; G Rhys Williams
Journal:  J Clin Epidemiol       Date:  2003-05       Impact factor: 6.437

2.  What does the PANSS mean?

Authors:  Stefan Leucht; John M Kane; Werner Kissling; Johannes Hamann; Eva Etschel; Rolf R Engel
Journal:  Schizophr Res       Date:  2005-06-27       Impact factor: 4.939

3.  Linking the PANSS, BPRS, and CGI: clinical implications.

Authors:  Stefan Leucht; John M Kane; Eva Etschel; Werner Kissling; Johannes Hamann; Rolf R Engel
Journal:  Neuropsychopharmacology       Date:  2006-07-05       Impact factor: 7.853

4.  Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: an open randomized clinical trial (EUFEST).

Authors:  Han Boter; Joseph Peuskens; Jan Libiger; W Wolfgang Fleischhacker; Michael Davidson; Silvana Galderisi; René S Kahn
Journal:  Schizophr Res       Date:  2009-10-09       Impact factor: 4.939

5.  Should the PANSS be rescaled?

Authors:  Michael Obermeier; Andreas Mayr; Rebecca Schennach-Wolff; Florian Seemüller; Hans-Jürgen Möller; Michael Riedel
Journal:  Schizophr Bull       Date:  2009-11-04       Impact factor: 9.306

6.  [Conceptual aspects in development and implementation of basic psychiatric documentation].

Authors:  C Cording
Journal:  Psychiatr Prax       Date:  1998-07

7.  Remission and cognitive ability in a cohort of patients with schizophrenia.

Authors:  Lars Helldin; John M Kane; Ulla Karilampi; Torsten Norlander; Trevor Archer
Journal:  J Psychiatr Res       Date:  2006-09-11       Impact factor: 4.791

Review 8.  Assessing clinical significance in measuring oncology patient quality of life: introduction to the symposium, content overview, and definition of terms.

Authors:  Jeff A Sloan; David Cella; Marlene Frost; Gordon H Guyatt; Mirjam Sprangers; Tara Symonds
Journal:  Mayo Clin Proc       Date:  2002-04       Impact factor: 7.616

9.  Responsiveness and validity in health status measurement: a clarification.

Authors:  G H Guyatt; R A Deyo; M Charlson; M N Levine; A Mitchell
Journal:  J Clin Epidemiol       Date:  1989       Impact factor: 6.437

10.  Psychopathological characteristics and treatment response of first episode compared with multiple episode schizophrenic disorders.

Authors:  Markus Jäger; Michael Riedel; Thomas Messer; Gerd Laux; Herbert Pfeiffer; Dieter Naber; Lutz G Schmidt; Wolfgang Gaebel; Wolfgang Huff; Isabella Heuser; Kai-Uwe Kühn; Matthias R Lemke; Eckart Rüther; Gerhard Buchkremer; Markus Gastpar; Ronald Bottlender; Anton Strauss; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-02       Impact factor: 5.270

View more
  1 in total

1.  Adapting the multilevel model for estimation of the reliable change index (RCI) with multiple timepoints and multiple sources of error.

Authors:  Antonio Alexander Morgan-Lopez; Lissette Maria Saavedra; Derek D Ramirez; Luke M Smith; Anna Catherine Yaros
Journal:  Int J Methods Psychiatr Res       Date:  2022-02-07       Impact factor: 4.182

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.